Brief: Cytocom Plans To Adopt New Corporate Name "Statera Biopharma, Inc."
31/08/2021 12:36
Aug 31 (Reuters) - Cytocom Inc CBLI.O :
* CYTOCOM, INC. ANNOUNCES PLAN TO ADOPT NEW CORPORATE NAME
"STATERA BIOPHARMA, INC."
Source text for Eikon: ID:nPn6lzsF1a
Further company coverage: CBLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc